Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial

article OA: closed CC0 ⤵ 42 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-06

This randomized trial compared estroprogestin alone versus gonadotropin agonists plus estroprogestin for treating endometriosis-related pelvic pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosis

MeSH descriptors

Endometriosis Estradiol Gonadotropin-Releasing Hormone Luteolytic Agents Pain Progesterone Triptorelin Pamoate Adult Dysmenorrhea Dysmenorrhea Dysmenorrhea Endometriosis Endometriosis Estradiol Estradiol Female Follow-Up Studies Gonadotropin-Releasing Hormone Humans Luteolytic Agents

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Cited by (42)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:13:41.710148+00:00
License: CC0 · commercial use OK